insights_auto
Waarom is DNA gedaald 2,09%?
Meer informatiechevron_right
DNA:NYSE
Ginkgo Bioworks
US$ 9,86
arrow_downward
-2,09%(-0,21) 1D
US$ 9,85
arrow_downward
-0,10% (-0,0100)bedtimeNa sluitingstijd
Gesloten: 20 okt, 16:00:04 GMT-4 · USD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor DNA genereren…
Openen
US$ 10,12
Hoog
US$ 10,38
Laag
US$ 9,85
Beursw.
634,40 mln.
Gem. vol.
3,00 mln.
Volume
592,00
52 wk hoog
US$ 18,22
52 wk laag
US$ 5,37
WPA
US$ -5,00
Bèta
1,79
Uitstaande aandelen
55,38 mln.
Aantal medewerkers
485
Openen
US$ 10,12
Hoog
US$ 10,38
Laag
US$ 9,85
Beursw.
634,40 mln.
Gem. vol.
3,00 mln.
Volume
592,00
52 wk hoog
US$ 18,22
52 wk laag
US$ 5,37
WPA
US$ -5,00
Bèta
1,79
Uitstaande aandelen
55,38 mln.
Aantal medewerkers
485
Nieuwsartikelen
Van webbronnen en nieuwspartners
Zacks
·
10 uur geleden
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know
Yahoo Finance
·
11 uur geleden
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know
Investing.com Canada
·
1 dag geleden
Form 144 Ginkgo Bioworks Holdings For: 20 October By Investing.com
Profiel
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
Over Ginkgo Bioworks
CEOJason Kelly
Medewerkers485
Opgericht2008
HoofdkantoorBoston, Massachusetts, Verenigde Staten
Sector-
Websiteginkgo.bio